Real-life dosing with second-generation antipsychotics

被引:11
|
作者
Correll, CU [1 ]
机构
[1] Zucker Hillside Hosp, Glen Oaks, NY 11004 USA
关键词
D O I
10.4088/JCP.v66n1218
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
[No abstract available]
引用
收藏
页码:1610 / 1611
页数:2
相关论文
共 50 条
  • [34] Metabolic risk in selected second-generation antipsychotics
    Kerna, V.
    Nosalova, G.
    Ondrejka, I
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2010, 111 (12): : 640 - 643
  • [35] Interactions between antiepileptics and second-generation antipsychotics
    de Leon, Jose
    Santoro, Vincenza
    D'Arrigo, Concetta
    Spina, Edoardo
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2012, 8 (03) : 311 - 334
  • [36] Second-generation antipsychotics in treating bipolar disorder
    Gentile, Salvatore
    SALUD I CIENCIA, 2010, 17 (04): : 325 - 329
  • [37] Dominance of second-generation antipsychotics - time for reflection?
    Underwood, Benjamin R.
    PSYCHIATRIC BULLETIN, 2007, 31 (06): : 233 - 233
  • [38] Second-Generation Antipsychotics and Extrapyramidal Adverse Effects
    Divac, Nevena
    Prostran, Milica
    Jakovcevski, Igor
    Cerovac, Natasa
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [39] Are Second-Generation Antipsychotics Useful in Tardive Dystonia?
    Pinninti, Narsimha Reddy
    Faden, Justin
    Adityanjee, Adit
    CLINICAL NEUROPHARMACOLOGY, 2015, 38 (05) : 183 - 197
  • [40] Polypharmacy with Second-Generation Antipsychotics: A Review of Evidence
    Pandurangi, Anand K.
    Dalkilic, Alican
    JOURNAL OF PSYCHIATRIC PRACTICE, 2008, 14 (06) : 345 - 367